Related Experiment Video
Updated: Jun 22, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Patent foramen ovale as a risk factor for cryptogenic stroke
M Di Tullio1, R L Sacco, A Gopal
1Columbia-Presbyterian Medical Center, New York, New York.
Insights
Patent foramen ovale is more common in cryptogenic stroke patients, indicating it
Area of Science:
- Cardiology
- Neurology
- Echocardiography
Background:
- Patent foramen ovale (PFO) is a common cardiac anomaly.
- Its role in cryptogenic stroke remains debated.
Purpose of the Study:
- To compare PFO prevalence in cryptogenic vs. determined stroke.
- To evaluate PFO as a risk factor for cryptogenic stroke.
Main Methods:
- Cross-sectional study with nested case-control analysis.
- 146 acute ischemic stroke patients evaluated.
- Contrast echocardiography used to detect PFO, blinded to stroke type.
Main Results:
- Overall PFO prevalence was 18%.
- PFO prevalence was significantly higher in cryptogenic stroke (31%) vs. determined stroke (69%) across all age groups.
- PFO strongly associated with cryptogenic stroke (OR, 7.2).
Conclusions:
- PFO is a significant risk factor for cryptogenic stroke.
- Higher PFO prevalence observed in cryptogenic stroke patients, irrespective of age.
- Contrast echocardiography recommended for unknown stroke causes.
Objective:
To determine and compare the prevalence of patent foramen ovale in patients with stroke of undetermined origin (cryptogenic) and in patients with stroke of determined origin to assess the possible role of patent foramen ovale as a risk factor for cryptogenic stroke.
Design:
Cross-sectional study with nested case-control analysis.
Patients:
A total of 146 patients (73 men, 73 women) with acute ischemic stroke referred to the echocardiography laboratory for evaluation.
Setting:
Neurovascular Unit and Echocardiography Laboratory, Columbia-Presbyterian Medical Center, New York, New York.
Measurements:
Patients were considered to have strokes of determined origin or cryptogenic strokes according to National Institute of Neurological Disorders and Stroke (NINDS) Stroke Data Bank criteria. The presence of patent foramen ovale was assessed by contrast echocardiography, performed blinded for type of stroke. The association between patent foramen ovale and type of stroke was tested after correcting for patients' demographic variables and stroke risk factors.
Results:
The overall prevalence of patent foramen ovale was 26 of 146 patients (18%; 95% Cl, 11.4% to 24.6%). Patients with cryptogenic stroke (31%) had a significantly higher prevalence of patent foramen ovale than did patients with an identifiable cause of stroke (69%) in both the younger (less than 55 years; 48% compared with 4%; P less than 0.001) and the older (greater than or equal to 55 years; 38% compared with 8%; P less than 0.001) age groups. Multiple logistic regression analysis was used to identify the presence of a patent foramen ovale as strongly associated with the diagnosis of cryptogenic stroke (odds ratio, 7.2; Cl, 2.4 to 21.7), irrespective of patient age and other stroke risk factors.
Conclusions:
Patients with cryptogenic stroke have a higher prevalence of patent foramen ovale than patients with stroke of determined cause in all age groups, even after correcting for the presence of recognized stroke risk factors. This identifies patent foramen ovale as a risk factor for cryptogenic stroke. Regardless of patient age, contrast echocardiography should be considered when the cause of stroke is unknown.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

